Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report
- PMID: 30660783
- DOI: 10.1016/j.chest.2018.11.030
Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report
Erratum in
-
Erratum to: CHEST 2019;155(3):565-586.Chest. 2021 Jan;159(1):457. doi: 10.1016/j.chest.2020.11.021. Chest. 2021. PMID: 33422229 No abstract available.
Abstract
Background: Pulmonary arterial hypertension (PAH) carries a poor prognosis if not promptly diagnosed and appropriately treated. The development and approval of 14 medications over the last several decades have led to a rapidly evolving approach to therapy, and have necessitated periodic updating of evidence-based treatment guidelines. This guideline statement, which now includes a visual algorithm to enhance its clinical utility, represents the fourth iteration of the American College of Chest Physicians Guideline and Expert Panel Report on Pharmacotherapy for PAH.
Methods: The guideline panel conducted an updated systematic review to identify studies published after those included in the 2014 guideline. A systematic literature search was conducted using MEDLINE via PubMed and the Cochrane Library. The quality of the body of evidence was assessed for each critical or important outcome of interest using the Grading of Recommendations Assessment, Development and Evaluation approach. Graded recommendations and ungraded consensus-based statements were developed and voted on using a modified Delphi technique to achieve consensus.
Results: Two new recommendations on combination therapy and two ungraded consensus-based statements on palliative care were developed. An evidence-based and consensus-driven treatment algorithm was created to guide the clinician through an organized approach to management, and to direct readers to the appropriate area of the document for more detailed information.
Conclusions: Therapeutic options for the patient with PAH continue to expand through basic discovery, translational science, and clinical trials. Optimal use of new treatment options requires prompt evaluation at an expert center, utilization of current evidence-based guidelines, and collaborative care using sound clinical judgment.
Keywords: evidence-based medicine; guidelines; pulmonary arterial hypertension (PAH).
Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Comment in
-
Request to "Update" the 2019 Update of Guidelines for Management of Pulmonary Arterial Hypertension.Chest. 2019 Jul;156(1):187. doi: 10.1016/j.chest.2019.03.038. Chest. 2019. PMID: 31279369 No abstract available.
-
Response.Chest. 2019 Jul;156(1):187-188. doi: 10.1016/j.chest.2019.03.039. Chest. 2019. PMID: 31279370 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
